Prevalence and incidence of NIDDM in Iceland: Evidence for stable incidence among males and females 1967-1991 - The Reykjavik Study

Diabetic Medicine

Volumn 14, Issue 6, 1997, Pages 491-498

  Vilbergsson, S ^a,b   Sigurdsson, G ^a,c   Sigvaldason, H ^a   Hreidarsson, A B ^d   Sigfusson, N ^a  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c Reykjavik City Hospital   (Iceland)

^d Landspitalinn   (Iceland)

Author keywords

Epidemiology; Iceland; Incidence; Non insulin dependent (Type 2) diabetes mellitus; Prevalence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; HUMAN; ICELAND; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX DIFFERENCE;

ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; ICELAND; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0030799976     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1     Document Type: Article

References (28)

1. Helgason T, Danielsen R, Thórsson ÁV. Incidence and prevalence of type 1 (insulin-dependent) diabetes mellitus in Icelandic children 1970-1989. Diabetologia 1992; 35: 880-883.
2. Groop P, Klaukka T, Reunanen A, Bergman U, Borch-Johnsen K, Damsgaard EM, et al. Antidiabetic Drugs in the Nordic Countries. Reasons for Variation in Their Use. Helsingfors: Folkpensionsanstaltens puplikationer, 1991.
3. Hreidarsson ÁB, Geirsson RT, Helgason T. Diabetes mellitus in Iceland: prevalence, organization of services, pregnancy outcome and long-term complications. Diab Nutr Metab 1993; 6: 333-334.
4. Alberti KGMM. World aspects of diabetes. Diabetic Med 1986; 3: 103-105.
5. King H, Zimmet P. Trends in the prevalence and incidence of non insulin dependent diabetes. World Health Statistics Quarterly 1988; 41: 190-196.
6. Ramachandran A. Increasing prevalence of NIDDM: a public health problem of developing nations. Dialogue 1994; first quarter: 11-15.
7. Neil HAW, Gatling W, Mather HM, et al. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Med 1987; 4: 539-543.
8. Katsilambros N, Aliferis K, Darviri Ch, Tsapogas P, Alexiou Z, Tritos N et al. Evidence for an increase in the prevalence of known diabetes in a sample of an urban population in Greece. Diabetic Med 1993; 10: 87-90.
9. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. II: The Design and Analysis of Cohort Studies. Lyon: IARC Scientific Publications No. 82. IARC, 1987.
10. Gebski V, Leung O, McNeil D, Lunn D. SPIDA User's Manual. Version 6. Statistical Computing Laboratory, Macquarie University, Macquarie, NSW, Australia: 1992.
11. Anderson DKG, Svärdsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabetic Med 1991; 8: 428-434.
12. Ohlson L-O, Larson B, Eriksson H, Svärdsudd K, Welin L, Tibblin G. Diabetes mellitus in Swedish middle-aged men. The study of men born 1913 and 1923. Diabetologia 1987; 30: 386-393.
13. Antti Reunanen. Prevalence and incidence of type 2 in Finland. Acta Endocrinologica 1984; 262: 31-35.
14. Wilson PW, McGee DL, Kannel WB. Obesity, very low lipoproteins, and glucose intolerance over fourteen years. The Framingham Study. Am J Epidemiol 1981; 114: 697-704.
15. Melton LJ, Palumbo J, Chu CP. Incidence of diabetes mellitus by clinical type. Diabetes Care 1983; 6: 75-86.
16. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengard JH, Pitkänen, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 1991; 20: 1010-1017.
17. Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J 1985; 291: 1081-1084.
18. Garancini MP, Calori G, Ruotolo G, Manara E, Izzo A, Ebbli E, et al. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia 1995; 38: 306-313.
19. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 1987; 36; 523-534.
20. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia 1993; 36: 1198-1203.
21. King H. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16; 157-177.
22. World Health Organization Expert Committee. Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series 310, Geneva: WHO, 1965.
23. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
24. World Health Organization Study Group. Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series 727, Geneva: WHO, 1985.
25. Sisk CW, Burnham CE, McDonald GA. Comparison of the 50 and 100 gram oral glucose tolerance test. Diabetes 1970; 19: 852-862.
26. de Nobel E, van't Laar A. The size of the loading dose as an important determinant of the results of the oral glucose tolerance test. Diabetes 1978; 27: 42-48.
27. Alberti KGMM. Problems related to definitions and epidemiology of type 2 (non-insulin-dependent) diabetes mellitus: studies throughout the world. Diabetologia 1993; 36: 978-984.
28. Helgason T, Jónasson MR. Evidence for a food additive as a cause of ketosis-prone diabetes. Lancet 1981; 2: 716-720.